| | |
| Clinical data | |
|---|---|
| Other names | CPC-10997; Cyoctol; X-Andron |
| Routes of administration | By mouth, topical |
| Drug class | Nonsteroidal antiandrogen |
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C16H28O2 |
| Molar mass | 252.398 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Cioteronel (INN , USAN ; developmental code CPC-10997; former tentative brand names Cyoctol, X-Andron) is a nonsteroidal antiandrogen (NSAA) that was never marketed. [1] [2] [3] It was under development between 1989 and 2001 for the topical treatment of androgenetic alopecia (male pattern baldness), and acne and for the oral treatment of benign prostatic hyperplasia; it reached phase III clinical trials for acne and phase II studies for androgenetic alopecia, but was ultimately discontinued due to poor efficacy. [3] [4]